Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Total Current Liabilities (2016 - 2026)

Champions Oncology (CSBR) has 15 years of Total Current Liabilities data on record, last reported at $22.1 million in Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 17.39% year-over-year to $22.1 million; the TTM value through Oct 2025 reached $22.1 million, up 17.39%, while the annual FY2025 figure was $23.9 million, 10.73% up from the prior year.
  • Total Current Liabilities reached $22.1 million in Q4 2025 per CSBR's latest filing, down from $22.7 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $23.9 million in Q2 2025 and bottomed at $11.2 million in Q1 2021.
  • Average Total Current Liabilities over 5 years is $18.4 million, with a median of $19.5 million recorded in 2024.
  • Peak YoY movement for Total Current Liabilities: skyrocketed 56.08% in 2022, then decreased 9.97% in 2024.
  • A 5-year view of Total Current Liabilities shows it stood at $12.5 million in 2021, then surged by 50.31% to $18.7 million in 2022, then increased by 11.82% to $21.0 million in 2023, then fell by 9.97% to $18.9 million in 2024, then increased by 17.39% to $22.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $22.1 million in Q4 2025, $22.7 million in Q3 2025, and $23.9 million in Q2 2025.